Prognostic factors in esophageal cancer

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 736-740

  Kunisaki, Chikara ^a   Shimada, Hiroshi ^a   Akiyama, Hirotoshi ^a   Nomura, Masato ^a   Matsuda, Goro ^a   Ono, Hidetaka ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cyclin D1; E cadherin; Esophageal Cancer; Lymph node metastasis

Indexed keywords

CYCLIN D1; PROTEIN P16; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CORRELATION ANALYSIS; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LYMPH NODE METASTASIS; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 2342514781     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Law S, Wong J: What is appropriate treatment for carcinoma of the thoracic esophagus? World J Surg 2001; 25:189-195.
2. Shiozaki H, Tahara H, Oka H, et al: Expression of immuno-reactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991; 139:17-23.
3. Shinozaki H, Ozawa S, Ando N, et al: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 1996; 2:1155-1161.
4. Hussussian CJ, Struewing JP, Goldstein AM, et al: Germline p16 mutations in familial melemona. Nature Genetics 1994; 8:15-21.
5. Sobin LH, Wittekind C (Eds.): UICC TNM Classification of Malignant Tumors. 5th Edition. New York: Wiley-Liss, 1977; pp. 65-68.
6. Akiyama H, Tsurumaru M, Udagawa H, et al: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220:364-373.
7. DeMesseter TR: Esophageal carcinoma: current controversies. Semin Surg Oncol 1997; 13:217-233.
8. Isono K, Sato H, Kanayama K: Results of a nationwide study on the three fields of lymph node dissection in esophageal cancer. Oncology 1991; 48:411-420.
9. Kato H, Watanabe H, Tachimori Y, et al: Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991; 51:151-157.
10. Nishihira T, Hirayama K, Mori S: A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998; 175:47-51.
11. Fujita H, Kakegawa T, Yamane H, et al: Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer: comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222:654-662.
12. Kawanishi K, Shiozaki H, Doki Y, et al: Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 1999; 85:1649-1657.
13. Tamura S, Shiozaki H, Miyata M, et al: Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the esophagus. Br J Surg 1996; 83:1608-1614.
14. Kadowaki T, Shiozaki H, Inoue M, et al: E-cadherin and α-catenin expression in human esophageal cancer. Cancer Research 1994; 54:291-296.
15. Shiozaki H, Doki Y, Kawanishi K. et al: Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. Surg 2000; 127:552-561.
16. Awad S, Doki Y, Shiozaki H, et al: Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma. Int J Oncol 1998; 13:455-460.
17. Johnson DJ, Schwarz JK, Cress WD, et al: Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365:349-352.
18. Ewen ME: The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev 1994; 13:45-66.
19. Jiang W, Zhang YJ, Kahn SM, et al: Altered expression of cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993; 90:9026-9030.
20. Tony H, Jonathon P: Cyclins and cancer II: cyclin D and CDK inhibitors come to age. Cell 1994; 79:573-582.
21. Montesano R, Hollstein M, Hainaut P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis. Int J Cancer 1996; 69:225-235.
22. Ikeda G, Isaji S, Das BC, et al: Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 1999; 86:1396-1405.
23. Nelson WJ, Shore EM, Wang AZ, et al: Identification of a membrane-cytoskeletal complex containing the cell adhesion molecule uvomorulin (E-cadherin), ankyrin, and fodrin in Madin-Darby canine kidney epithelial cells. J Cell Biol 1990; 110:349-357.
24. Vleminckx K, Vakaet L Jr, Mareel M, et al: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 166:107-119.
25. Frixen UH, Behrens J, Sachs M, et al: E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113:173-185.
26. Mori T, Miura K, Aoki T, et al: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 1994; 54:3367-3369.
27. Liu Q, Yan YX, McClure M, et al. MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene 1995; 10:619-622.